Last updated: Sep 28, 2026, 12:00 AM

Hapvida Participações e Investimentos S.A. Exchange (SA, BRL)

HAPV3.SA

6.65
-0.15 (-2.21%)
Financial ServicesInsurance - Life
Invest Today
Invest Today
1 year return (CAGR)
-82.58%
3 year return (CAGR)
-53.04%
5 year return (CAGR)
-50.67%
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
3.16B
Price/Sales
0.17
Ent value
26.89B
Price/Book
0.07
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
5.63
EPS growth
-

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open6.66
Daily high6.90
Daily low6.59
Daily Volume6.73M
All-time high58.35
1y analyst estimate12.04
Beta0.20
EPS (TTM)-0.37
Dividend per share0.00
Ex-div date27 Dec 2021
Next earnings date26 Mar 2026

Ready to capitalize on Hapvida Participações e Investimentos S.A.'s growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
HAPV3.SAS&P500
Current price drop from All-time high-88.60%-1.29%
Highest price drop-95.08%-56.47%
Date of highest drop4 Jun 20259 Mar 2009
Avg drop from high-41.74%-10.68%
Avg time to new high31 days12 days
Max time to new high944 days1805 days
News
Hapvida Participacoes Investimento SA (BSP:HAPV3) navigates a pivotal quarter with a 12-month plan to reprice contracts, cut costs, and reduce litigation pressure despite a slight membership dip.
August 15, 2026
The recent reset in the fair value estimate for Hapvida Participações e Investimentos from R$26.09 to R$13.96 sits alongside price targets such as R$19 that frame a more conservative central case for ...
June 20, 2026
Hapvida Participacoes Investimento SA (BSP:HAPV3) outlines its strategic initiatives and financial strategies to navigate market complexities and enhance operational efficiency.
May 13, 2026
Discover how Hapvida Participacoes Investimento SA (BSP:HAPV3) is navigating technological advancements and market expansion while addressing cost and regulatory hurdles.
November 13, 2025